Management Team
團隊介紹
MS
Maggie Yang
- Executive Director of Clinical Development
Ms. Maggie Yang joined Elixiron Immunotherapeutics Inc. in Aug 2024, responsible for Clinical Development and Clinical Operations.
Before joining Elixiron Immunotherapeutics Inc., Maggie worked for pharmaceutical, biotech and CRO companies for more than 25 years, including GlaxoSmithKline, Pfizer, OBI and Parexel, with focus on clinical operations, project delivery, and quality management, covering the sites in Taiwan, Asia Pacific and the United State.
Maggie received her B.Sc. and M.Sc. degree from National Chung Hsing University, major in veterinary medicine.
BACK
返回
Before joining Elixiron Immunotherapeutics Inc., Maggie worked for pharmaceutical, biotech and CRO companies for more than 25 years, including GlaxoSmithKline, Pfizer, OBI and Parexel, with focus on clinical operations, project delivery, and quality management, covering the sites in Taiwan, Asia Pacific and the United State.
Maggie received her B.Sc. and M.Sc. degree from National Chung Hsing University, major in veterinary medicine.
